InvestSMART

Imricor Medical Systems Inc (ASX:IMR)

ALERT: Price-sensitive ASX Announcement for IMR
Current share price for IMR : $1.450 -0.445 (-23.48%)+
Announcement
Release
7 Aug 2026 8:31AM
Price at Release
$1.895
Full Release
download
Summary
Imricor Medical Systems, Inc. has announced a significant development in their collaboration with Philips. Philips has issued a Third Party Product Compatibility Declaration, affirming the compatibility of Imricor's interventional magnetic resonance (iMR) products with Philips magnetic resonance systems. This declaration includes compatibility with five initial MR systems and four system upgrades, all operating on software versions R12.1.1 or greater. This compatibility facilitates the installation of Imricor’s NorthStar mapping and guidance system at Philips iMR sites, notably the German Heart Center of Charité in Berlin. The collaboration also extends to co-sponsoring sessions at the European Society of Cardiology (ESC) Congress. Imricor is recognized for its pioneering efforts in MR-compatible products, aiming to make medical procedures safer and more cost-effective through real-time MR guidance.
Key Points
  • Philips declares compatibility of its MR systems with Imricor's products.
  • Compatibility covers Imricor’s NorthStar mapping system and other products.
  • Co-sponsorship of iMR sessions at the ESC Congress by Imricor and Philips.
  • Installation of Imricor technology at the German Heart Center of Charité.
  • Focus on enhancing iMR guided procedures and safety through collaboration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.